Archive for April, 2012

Recent Rosacea Blog Posts

How much does Galderma earn each year from Oracea sales ? Well the actual amount is not published, but in September 2011 court proceedings we learnt that Mylan Pharmaceuticals projected sales of $260m in 2011 for Oracea. The parent company of Galderma, L’Oreal does not publish Oracea sales figures, so this press release is as […]

Continue Reading

“Medical Crowdsourcing” via CureTogether – the new cheap data collection method

A recent article in the Dermatology Online Journal introduced me to a new online support group site. Apparently curetogether.com is a major medical crowdsourcing site. What is crowdsourcing? Well crowdsourcing is a new buzzword which basically means to get your information from the “crowd” or as many people as you can. Online this term generally […]

Continue Reading

Oracea is Not an Antibiotic, Apparently

This claim from the Oracea web site caught my eye. Oracea is NOT an antibiotic. A bit of poetic marketing license perhaps? Oracea is a 40mg dose of the antibiotic doxycycline, which is a member of the tetracycline family. 30mg of the dose of doxycycline is immediate release, and 10 mg is locked inside a […]

Continue Reading

Theory: Ivermectin is Metrogel’s Cousin, Help Needed

OK, bear with me. I don’t often just waffle here as a Rosacea News item. Maybe I should. Anyway this post is just me exploring an idea. From my high school organic chemistry it seems to me that Ivermectin and Metrondizole are in fact chemically akin to cousins. I started to think about this because […]

Continue Reading

The mysterious CD5024 1% Cream for which Galderma is conducting a large Phase III trial, has further been confirmed as the anti-parasitic Ivermectin. This latest confirmation comes from the World Heath Organisation’s International Clinical Trials Registry Platform Search Portal. The search for CD5024 reveals trials that have completed in the Czech Republic, Germany and Hungary. The […]

Continue Reading

 

Top

Subscribe to Rosacea News

Enter your email address to receive the latest news about rosacea in your inbox.